Delivery Order SPE2DB20D1004-SPE2DB24FG6P6

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,332.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FCVYE) for the supply of Timolol Maleate 0.5% eye drops in unit-dose packaging. The contract has a firm fixed price and an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,393.48, is for the delivery of Timolol Maleate 0.5% eye drops in 60-count units. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,331.04 contract is for the delivery of Timolol Maleate 0.5% eye drops, a cardiovascular medication, to support federal healthcare programs. The contract has an ultimate completion date of March 6, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol Maleate 0.5% eye drops, with a total ceiling value of $1,048.32 and a completion date of September 21, 2022. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose 60s packaging. The firm-fixed-price delivery order, valued at $1,173.52, has an ultimate completion date of January 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,802.75 fixed-price delivery order is for 4,567,465,230 units of Timolol Maleate 0.25% eye drops, which are a treatment for glaucoma. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose packaging. The $1,403.68 Firm Fixed Price delivery order contract has an ultimate completion date of April 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,165.76, is a Firm Fixed Price Delivery Order contract for the supply of Timolol 0.5% eye drops (5 ml). The contract has an ultimate completion date of August 20, 2024 and is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, with a total ceiling value of $1,048.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Timolol Maleate 0.5% eye drops in unit doses of 60 units. This is a firm-fixed-price delivery order contract with a completion date of July 21, 2022. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,362.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop, to support military healthcare programs. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG6P6
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $1,387.04 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565440519 - Timolol Maleate 0.5% Eye Drops, 15ml, with a completion date of August 14, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:27 AM